Publications
- The translocation t(2;11)(p21;q23) without MLL gene rearrangement-a possible marker of good prognosis in myelodysplastic syndrome patients2014 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice2014 | First Faculty of Medicine
- Characterization of chromosome 11 breakpoints and the areas of deletion and amplification in patients with newly diagnosed acute myeloid leukemia2013 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Notes to the pathophysiology of myelodysplastic syndrome, demethylation therapy and the role of cytokine-induced differentiation2013 | First Faculty of Medicine
- Initial experience of Czech MDS Group with 5-azacytidine in patients with high risk myelodysplastic syndromes (IPSS intermediate II and high), acute myeloid leukaemia with less than 30% myeloblasts and chronic myelomonocytic leukaemia II2013 | First Faculty of Medicine
- Changes associated with lenalidomide treatment in the gene expression profiles of patients with Del(5q)2012 | First Faculty of Medicine
- Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports2012 | First Faculty of Medicine
- 5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity2012 | First Faculty of Medicine
- Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases - principles and rationale of CZEMP recommendations2011 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation2011 | First Faculty of Medicine
Loading network view...